Cardlytics (CDLX) Reports Acquisition of Dosh for $275M in Cash and Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Cardlytics (CDLX) Prices 3.85M Share Common Offering at $130/Sh
March 3, 2021 6:11 AM ESTCardlytics, Inc. (NASDAQ: CDLX) today announced the pricing of an underwritten public offering of 3,850,000 shares of its common stock, at a price to the public of $130.00 per share. The gross proceeds to Cardlytics from the offering, before deducting underwriting discounts and commissions and... More
Cardlytics (CDLX) Misses Q4 EPS by 2c, Revenues Beat; Offers FY21 Revenues Mid-Point Guidance Above Consensus
March 1, 2021 6:43 AM ESTCardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $67.1 million versus the consensus estimate of $60.89 million.
Fourth Quarter 2020 Financial Results
Total revenue was $67.1 million, a decrease of (3.2)%, compared to $69.3 million in the fourth quarter of 2019.Net loss attributable to common stockholders was $(6.8) million, or $(0.24) per diluted share, based on 27.7 million weighted-average common shares outstanding, compared to a net income attributable to common stockholders of $3.4 million, or $0.12 per diluted... More